oldid65459

Terapia allocates 750,000 euros for research

Terapia Cluj-Napoca pharmaceutical company will invest 750,000 euros in a bio-equivalence centre to be finalised by mid this month. The investment will allow the company to double its bio-equivalence research capacity. The bio-equivalence research is a necessa...